67 Results for "

MAGL

" in MedChemExpress (MCE) Product Catalog:
Products (67)

67 Results for "MAGL" in MCE Product Catalog:

  • Categories Recommended:
    More
Cat. No.: HY-15249R
CAS No.: 1101854-58-3
Research Areas:  

Neurological Disease

JZL 184 (Standard) is the analytical standard of JZL 184. This product is intended for research and analytical applications. JZL 184 is a potent, selective and irreversible MAGL inhibitor that blocks 2-Arachidonoylglycerol (2-AG) hydrolysis in brain membranes (IC50 of 8 nM). JZL 184 displays >300-fold selectivity for MAGL over FAAH .
loading...
    loading...
Cat. No.: HY-121422
CAS No.: 1680193-80-9
Purity:  99.72%
Target:  

MAGL Histamine Receptor

Research Areas:  

Inflammation/Immunology

JZP-361 is a potent, reversible and selective inhibitor of human recombinant MAGL (hMAGL) with an IC50 of 46 nM. JZP-361 also shows antihistaminergic activities and can be used for asthma research .
loading...
    loading...
Cat. No.: HY-117771A
CAS No.: 2098969-71-0
Purity:  98.42%
Target:  

DAGL

DO34 analog is a structural analog of DO34 (HY-117771). DO34 is a selective DAGL inhibitor, with an IC50 of 6 nM for DAGLα conversion of SAG to 2-AG. DO34 blocks de novo 2-AG synthesis, and suppresses tonic CB1 receptor activation. DO34 blocks depolarization-induced suppression of excitation and inhibition in the cerebellum and hippocampus. DO34 regulates feeding behavior and locomotor activity in mice. DO34 abolishes AM251-mediated enhancement of parallel fiber-evoked excitatory postsynaptic currents in cerebellar slices from MAGL global knockout mice. DO34 can be used for the research of energy balance disorder and neuroinflammation .
loading...
    loading...
Cat. No.: HY-163733
CAS No.: 1515855-85-2
Target:  

FAAH MAGL

AKU-005 is a FAAH and MAGL dual inhibitor with IC50 values of 63, 389 nM for rat and human FAAH, respectively. AKU-005 has the potential for the research of trigeminal hyperalgesia .
loading...
    loading...
Cat. No.: HY-139182
CAS No.: 2514-37-6
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

CAY10762 is an inhibitor of monoacylglycerol lipase (MAGL; IC50=34.1 nM). It reduces hydrogen peroxide-induced lactate dehydrogenase (LDH) release from Neuro2a cells when used at a concentration of 1 μM. CAY10762 (10 mg/kg) increases levels of 2-arachidonoyl glycerol in mouse brain.
loading...
    loading...
Cat. No.: HY-150702
CAS No.: 2361575-20-2
Target:  

MAGL

MAGLi 432 is a non-covalent, potent, highly selective, and reversible MAGL inhibitor. MAGLi 432 binds with high affinity to the MAGL active site, with IC50 values of 4.2 nM (human enzyme) and 3.1 nM (mouse enzyme). MAGLi 432 can be used in the research of chronic inflammation, blood–brain barrier dysfunction, neurological disorders such as multiple sclerosis, Alzheimer’s disease and Parkinson’s disease .
loading...
    loading...
Cat. No.: HY-146342
CAS No.: 2848719-34-4
Target:  

FAAH MAGL

Research Areas:  

Neurological Disease

FAAH/MAGL-IN-3 (Compound 10) is an irreversible fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) dual inhibitor with IC50 values of 179 and 759 nM against FAAH and MAGL, respectively. FAAH/MAGL-IN-3 shows low PAMPA (Parallel Artificial Membrane Permeability Assay) permeability .
loading...
    loading...
Cat. No.: HY-143263
Target:  

FAAH MAGL

Research Areas:  

Neurological Disease

FAAH/MAGL-IN-1 (compound SIH 3) is a potent FAAH and MAGL inhibitor with IC50s of 31 nM and 29 nM, respectively. FAAH/MAGL-IN-1 has the potential for the research of neuropathic pain .
loading...
    loading...
Cat. No.: HY-162315
Target:  

MAGL

Research Areas:  

Neurological Disease

MAGL-IN-16 (compound 27) is an oral active, selective and reversible MAGL inhibitor with the IC50 value of 10.3 nM. MAGL-IN-16 can increase the level of 2-AG and shows antidepressant effect in mouse depressed model caused by chronic restraint stress .
loading...
    loading...
Cat. No.: HY-143264
CAS No.: 2765077-82-3
Target:  

FAAH MAGL

Research Areas:  

Neurological Disease

FAAH/MAGL-IN-2 is a potent, reversible, orally active, and cross the blood-brain barrier FAAH and MAGL inhibitor with IC50s of 11 nM and 36 nM (Kis of 28 nM and 60 nM), respectively . FAAH/MAGL-IN-2 has the potential to research neuropathic pain without causing locomotion impairment .
loading...
    loading...
Cat. No.: HY-103463
CAS No.: 1346169-63-8
Target:  

FAAH MAGL

Research Areas:  

Neurological Disease

SA57 is a potent, selective FAAH inhibitor with IC50s of 3.2 nM and 1.9 nM for mouse and human FAAH. SA57 also inhibits the 2-arachidonoylglycerol hydrolases MAGL (IC50s of 410 nM and 1.4 μM for mouse and human MAGL) and mouse α/β-hydrolase domain-containing protein 6 (mABHD6; IC50 of 850 nM), but not other brain serine hydrolases .
loading...
    loading...
Cat. No.: HY-124378
CAS No.: 1643657-35-5
Target:  

MAGL

Research Areas:  

Inflammation/Immunology

MAGL-IN-17 (Compound ) is an inhibitor for MAGL with a Ki of 0.4 μM. MAGL-IN-17 inhibits mouse MAGL and rat MAGL with IC50 of 0.18 and 0.24 μM. MAGL-IN-17 exhibits anti-inflammatory activity in mouse experimental autoimmune encephalitis models .
loading...
    loading...
Cat. No.: HY-157042
CAS No.: 3017151-84-4
Target:  

MAGL

Research Areas:  

Inflammation/Immunology Cancer

MAGL-IN-11 (compound 29) is a selective and reversible MAGL inhibitor. MAGL-IN-11 has the potential to study inflammation, cancer and antioxidants .
loading...
    loading...
Cat. No.: HY-145945
CAS No.: 2414320-29-7
Target:  

MAGL

Research Areas:  

Neurological Disease

MAGL-IN-6 is a potent MAGL inhibitor with an IC50 of 4.71 nM. MAGL-IN-6 can be used for neurological disorders research (WO2020065613A1; example 234) .
loading...
    loading...
Cat. No.: HY-168145
CAS No.: 2411570-42-6
Target:  

MAGL

Research Areas:  

Cancer

MAGL-IN-19 (compund 7o) is a highly potent and selective MAGL inhibitor .
loading...
    loading...
Cat. No.: HY-157040
CAS No.: 3017151-74-2
Target:  

MAGL

Research Areas:  

Inflammation/Immunology

MAGL-IN-9 (compound 16) is a selective and reversible MAGL inhibitor with IC50 2.7 nM .
loading...
    loading...
Cat. No.: HY-157041
CAS No.: 3017151-83-3
Target:  

MAGL

Research Areas:  

Cancer

MAGL-IN-10 is areversible monoacylglycerol lipase (MAGL) inhibitor with very good ADME properties and low in vivo toxicity.MAGL-IN-10 can be used for the research ofcancer, neurological disorders and inflammatory pathologies .
loading...
    loading...
Cat. No.: HY-168032
CAS No.: 3036792-74-9
Target:  

MAGL

Research Areas:  

Inflammation/Immunology

MAGL-IN-18 (compound 118) is a potent Monoacylglycerol lipase (MAGL) inhibitor with an IC50 of 0.03 nM .
loading...
    loading...
Cat. No.: HY-168459
Target:  

MAGL

Research Areas:  

Neurological Disease

MAGL-IN-21 (Compound (S)-6) is a selective inhibitor for monoacylglycerol lipase (MAGL) with an IC50 of 1.59 nM .
loading...
    loading...
Cat. No.: HY-157038
CAS No.: 3017151-71-9
Target:  

MAGL

Research Areas:  

Inflammation/Immunology

MAGL-IN-8 (compound 13) is a reversible monoacylglycerol lipase (MAGL) inhibitor, with an IC50 of 2.5 ± 0.4 nM for hMAGL .
loading...
    loading...